This inventor holds 1 USPTO granted patent. Top assignee: Schering Corporation. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Albert W Buchholz, Jr: Innovator in Pharmaceutical Chemistry
Introduction
Albert W Buchholz, Jr. is a notable inventor based in Bridgewater, NJ (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that address various physiological disorders.
Latest Patents
Buchholz holds a patent for "Xanthine phosphodiesterase V inhibitor polymorphs." This patent includes crystalline polymorphs of 1-ethyl-3,7-dihydro-8-[(1R,2R)-(hydroxycyclopentyl)amino]-3-(2-hydroxyethyl)-7-[(3-bromo-4-methoxyphenyl)methyl]-1H-Purine-2,6-dione in Form 1 and Form 2. These polymorphs exhibit x-ray powder diffraction profiles and differential scanning calorimetry profiles that are substantially the same as those shown in the respective figures. The patent also covers pharmaceutical compositions comprising these polymorphs and methods for using them to treat conditions such as erectile dysfunction. He has 1 patent to his name.
Career Highlights
Buchholz has worked with Schering Corporation, where he has been involved in innovative research and development. His work has contributed to advancements in pharmaceutical formulations and therapeutic applications.
Collaborations
He has collaborated with notable coworkers, including Craig D Boyle and Cecilia A Orr, enhancing the research efforts within his team.
Conclusion
Albert W Buchholz, Jr. is a distinguished inventor whose work in pharmaceutical chemistry has led to important advancements in treating physiological disorders. His contributions continue to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile